文献速递血栓与止血造血干细胞移植与细胞治疗

循环线粒体在胶质母细胞瘤静脉血栓形成中的作用

Role of circulating mitochondria in venous thrombosis in glioblastoma.
PubMed 文献 · J Thromb Haemost · 2023-05-11

研究评估了循环游离线粒体在胶质母细胞瘤(GBM)诱导的高凝状态中的作用。82例GBM患者血浆线粒体数量高于17例健康对照,且合并静脉血栓栓塞(VTE)者高于无VTE者;小鼠下腔静脉狭窄模型中静脉输注线粒体增加血栓形成率(70% vs 28%),血栓富含中性粒细胞和血小板;抗心磷脂IgG在VTE患者中更高。作者认为线粒体可能参与GBM相关高凝状态,定量循环线粒体或抗心磷脂抗体或可识别VTE高风险患者。

要点

  • GBM患者血浆线粒体数量高于健康对照(2.8×10^7 vs 0.3×10^7线粒体/mL,合并VTE者;1.9×10^7 vs 0.3×10^7线粒体/mL,无VTE者)。
  • GBM合并VTE患者(n=41)血浆线粒体浓度高于无VTE患者(n=41)。
  • 小鼠下腔静脉狭窄模型中,静脉输注线粒体组静脉血栓形成率70%,对照组28%。

核心结论

  • 作者结论认为线粒体可能参与GBM诱导的高凝状态。
  • 作者提出定量循环线粒体或抗心磷脂抗体浓度或可识别GBM患者中VTE风险增加者。

研究设计与样本

  • 研究检测GBM患者循环游离线粒体与静脉血栓形成的相关性,并在下腔静脉狭窄小鼠中观察线粒体对静脉血栓形成的影响。
  • 患者血浆样本来自82例GBM患者和17例健康对照。
  • 小鼠模型为下腔静脉狭窄模型。

主要发现

  • GBM合并VTE患者血浆线粒体为2.8×10^7线粒体/mL,GBM无VTE患者为1.9×10^7线粒体/mL,健康对照(n=17)为0.3×10^7线粒体/mL。
  • GBM合并VTE患者(n=41)线粒体浓度高于GBM无VTE患者(n=41)。
  • 小鼠下腔静脉狭窄模型中,静脉输注线粒体组静脉血栓形成率为70%,对照组为28%。
  • 线粒体诱导的静脉血栓富含中性粒细胞,且血小板含量高于对照血栓。
  • GBM合并VTE患者血浆抗心磷脂IgG浓度(光密度0.69±0.04)高于无VTE患者(光密度0.51±0.04)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many patients with glioblastoma multiforme (GBM) develop deep venous thrombosis or pulmonary emboli. Cell-free circulating mitochondria increase after brain injury and are associated with coagulopathy. OBJECTIVES: This study evaluated whether mitochondria play a role in the GBM-induced hypercoagulable state. METHODS: We examined the correlation between cell-free circulating mitochondria and venous thrombosis in patients with GBM and the impact of mitochondria on venous thrombosis in mice with inferior vena cava stenosis. RESULTS: Using plasma samples of 82 patients with GBM, we found that patients with GBM had a higher number of mitochondria in their plasma (GBM with venous thromboembolism [VTE],: 2.8 × 107 mitochondria/mL; GBM without VTE, 1.9 × 107 mitochondria/mL) than that in healthy control subjects (n = 17) (0.3 × 107 mitochondria/mL). Interestingly, patients with GBM and VTE (n = 41) had a higher mitochondria concentration than patients with GBM without VTE (n = 41). In a murine model of inferior vena cava stenosis, intravenous delivery of mitochondria resulted in an increased rate of venous thrombosis compared with that in controls (70% and 28%, respectively). Mitochondria-induced venous thrombi were neutrophil-rich and contained more platelets than those in control thrombi. Furthermore, as mitochondria are the only source of cardiolipin in circulation, we compared the concentration of anticardiolipin immunoglobulin G in plasma samples of patients with GBM and found a higher concentration in patients with VTE (optical density, 0.69 ± 0.04) than in those without VTE (optical density, 0.51 ± 0.04). CONCLUSION: We concluded that mitochondria might play a role in the GBM-induced hypercoagulable state. We propose that quantifying circulating mitochondria or anticardiolipin antibody concentrations in patients with GBM might identify patients at increased risk of VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Gonzalez-Delgado R, Muñoz NM, Carlos-Alcalde W, et al. Role of circulating mitochondria in venous thrombosis in glioblastoma. J Thromb Haemost. 2023. PMID: 37178770. doi:10.1016/j.jtha.2023.04.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。